Format

Send to

Choose Destination
See comment in PubMed Commons below
Nat Rev Microbiol. 2006 Jun;4(6):469-76.

Advances in tuberculosis vaccine strategies.

Author information

1
Aeras Global TB Vaccine Foundation, 1405 Research Blvd, Rockville, Maryland 20850, USA. yskeiky@aeras.org

Abstract

Tuberculosis (TB), an ancient human scourge, is a growing health problem in the developing world. Approximately two million deaths each year are caused by TB, which is the leading cause of death in HIV-infected individuals. Clearly, an improved TB vaccine is desperately needed. Heterologous prime-boost regimens probably represent the best hope for an improved vaccine regimen to prevent TB. This first generation of new vaccines might also complement drug treatment regimens and be effective against reactivation of TB from the latent state, which would significantly enhance their usefulness.

PMID:
16710326
DOI:
10.1038/nrmicro1419
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Nature Publishing Group
    Loading ...
    Support Center